Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma (RCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00743236
What this trial is testing

Warm Ischemia or Cold Ischemia During Surgery in Treating Patients With Stage I Kidney Cancer

Who this might be right for
Kidney CancerLong-term Effects Secondary to Cancer Therapy in AdultsPerioperative/Postoperative Complications+1 more
Wake Forest University Health Sciences 1
Not applicableNot Yet RecruitingNCT07480044
What this trial is testing

A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery

Who this might be right for
Postoperative Delirium (POD)Prostate CancerKidney Tumor
Zhejiang University 220
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Large-scale testing (Phase 3)UnknownNCT00003804
What this trial is testing

Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor

Who this might be right for
Kidney Cancer
University of Leicester 350
Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Testing effectiveness (Phase 2)Study completedNCT00012337
What this trial is testing

ZD 1839 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT00311545
What this trial is testing

S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
SWOG Cancer Research Network
Not applicableActive Not RecruitingNCT04919122
What this trial is testing

Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Duke University 468
Not applicableStudy completedNCT04601129
What this trial is testing

Advantage of a Fast-recovery Protocol for Minimally Invasive Kidney Surgery

Who this might be right for
Renal Cell Carcinoma
University Hospital, Lille 60
Testing effectiveness (Phase 2)WithdrawnNCT00176280
What this trial is testing

Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
University of Kentucky
Very early researchStudy completedNCT00405366
What this trial is testing

Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer

Who this might be right for
Kidney Cancer
UNC Lineberger Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT03967522
What this trial is testing

Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases

Who this might be right for
Metastatic Renal Cell Carcinoma
Centre Leon Berard 26
Testing effectiveness (Phase 2)Ended earlyNCT00467077
What this trial is testing

Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
California Cancer Consortium 21
Not applicableEnded earlyNCT01336231
What this trial is testing

Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer

Who this might be right for
Metastatic Kidney Cancer
Centre Francois Baclesse 82
Testing effectiveness (Phase 2)UnknownNCT01041482
What this trial is testing

A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Chinese Academy of Medical Sciences 140
Testing effectiveness (Phase 2)Study completedNCT00039429
What this trial is testing

Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Eastern Cooperative Oncology Group 180
Large-scale testing (Phase 3)Study completedNCT00018941
What this trial is testing

Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
National Cancer Institute (NCI)
Post-approval studies (Phase 4)Looking for participantsNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Testing effectiveness (Phase 2)Ended earlyNCT01342627
What this trial is testing

Sorafenib in Elderly Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Centro di Riferimento Oncologico - Aviano 4
Testing effectiveness (Phase 2)Looking for participantsNCT04299646
What this trial is testing

A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases

Who this might be right for
Metastatic Renal Cell CarcinomaRadiotherapy
Centre Francois Baclesse 77
Next Page